Skip to main content

Advertisement

Fig. 2 | Chinese Journal of Cancer

Fig. 2

From: Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

Fig. 2

Factors associated with mobilization yield in patients with high-risk non-Hodgkin’s lymphoma. a Positive correlation between total CD34+ cell yield and the percentage of CD34+ cells in peripheral blood on the first day of apheresis. b Negative correlation between total CD34+ cell yield and age

Back to article page